Metyrapone is an effective adjuvant treatment for major depression: Commentary

A.H. Young; J. Newham

doi:10.1136/ebmh.8.3.72

Metyrapone is an effective adjuvant treatment for major depression: Commentary

Research output: Contribution to journal › Comment/debate

Abstract

Patients: Sixty three people aged 18-75 years with a diagnosis of major depressive disorder (DSM-IV); a score of 18 or over on the Hamilton Rating Scale for Depression, 21 item version (HAMD-21); and free from antidepressant, antipsychotic, mood stabilising, and other medication for at least three days before the study began. CONCLUSIONS Addition of metyrapone to treatment with antidepressants improves symptoms of depression and accelerates the action of antidepressant drugs

Original language	English
Pages (from-to)	72-72
Number of pages	1
Journal	Evidence-Based Mental Health
Volume	8
Issue number	3
Early online date	25 Jul 2005
DOIs	https://doi.org/10.1136/ebmh.8.3.72
Publication status	Published - 1 Aug 2005
Externally published	Yes

Access to Document

10.1136/ebmh.8.3.72

Cite this

@article{1bb8efd068764884ba8e9bcee3d64598,

title = "Metyrapone is an effective adjuvant treatment for major depression: Commentary",

abstract = "Patients: Sixty three people aged 18-75 years with a diagnosis of major depressive disorder (DSM-IV); a score of 18 or over on the Hamilton Rating Scale for Depression, 21 item version (HAMD-21); and free from antidepressant, antipsychotic, mood stabilising, and other medication for at least three days before the study began. CONCLUSIONS Addition of metyrapone to treatment with antidepressants improves symptoms of depression and accelerates the action of antidepressant drugs",

author = "A.H. Young and J. Newham",

year = "2005",

month = aug,

day = "1",

doi = "10.1136/ebmh.8.3.72",

language = "English",

volume = "8",

pages = "72--72",

journal = "Evidence-Based Mental Health",

issn = "1362-0347",

publisher = "BMJ",

number = "3",

}

TY - JOUR

T1 - Metyrapone is an effective adjuvant treatment for major depression

T2 - Commentary

AU - Young, A.H.

AU - Newham, J.

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Patients: Sixty three people aged 18-75 years with a diagnosis of major depressive disorder (DSM-IV); a score of 18 or over on the Hamilton Rating Scale for Depression, 21 item version (HAMD-21); and free from antidepressant, antipsychotic, mood stabilising, and other medication for at least three days before the study began. CONCLUSIONS Addition of metyrapone to treatment with antidepressants improves symptoms of depression and accelerates the action of antidepressant drugs

AB - Patients: Sixty three people aged 18-75 years with a diagnosis of major depressive disorder (DSM-IV); a score of 18 or over on the Hamilton Rating Scale for Depression, 21 item version (HAMD-21); and free from antidepressant, antipsychotic, mood stabilising, and other medication for at least three days before the study began. CONCLUSIONS Addition of metyrapone to treatment with antidepressants improves symptoms of depression and accelerates the action of antidepressant drugs

U2 - 10.1136/ebmh.8.3.72

DO - 10.1136/ebmh.8.3.72

M3 - Comment/debate

SN - 1362-0347

VL - 8

SP - 72

EP - 72

JO - Evidence-Based Mental Health

JF - Evidence-Based Mental Health

IS - 3

ER -

Metyrapone is an effective adjuvant treatment for major depression: Commentary

Abstract

Access to Document

Fingerprint

Cite this